Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis
about
Targeting Low Disease Activity in Elderly-Onset Rheumatoid Arthritis: Current and Future Roles of Biological Disease-Modifying Antirheumatic DrugsWhat is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis?Increased TLR4 expression and downstream cytokine production in immunosuppressed adults compared to non-immunosuppressed adults.Sinus aspergilloma in rheumatoid arthritis before or during tumor necrosis factor-alpha antagonist therapyThe influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case-control study.Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomideAssessing immune function by profiling cytokine release from stimulated blood leukocytes and the risk of infection in rheumatoid arthritis.The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analysesImmunization in Patients with Rheumatic Diseases: A Practical Guide for General Practitioners.Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysisA large two-centre study in to rates of influenza and pneumococcal vaccination and infection burden in rheumatoid arthritis in the UK.Development and validation of a risk score for serious infection in patients with rheumatoid arthritis.Association of dialysis modality with risk for infection-related hospitalization: a propensity score-matched cohort analysisNo impact of concomitant methotrexate use on serious adverse event and serious infection risk in patients with rheumatoid arthritis treated with bDMARDs: a systematic literature review and meta-analysisSerum cotinine as a biomarker of tobacco exposure and the association with treatment response in early rheumatoid arthritis.Infection Risk and Safety of Corticosteroid Use.Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs.Inflammatory arthritis: an overview for primary care physicians.The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment.Interplay of infections, autoimmunity, and immunosuppression in systemic lupus erythematosus.Can side effects of steroid treatments be minimized by the temporal aspects of delivery method?Practical Management of Respiratory Comorbidities in Patients with Rheumatoid Arthritis.Using Multiple Pharmacovigilance Models Improves the Timeliness of Signal Detection in Simulated Prospective Surveillance.Short- and long-term mortality due to sepsis in patients with rheumatoid arthritis.Update on the use of rituximab for intractable rheumatoid arthritis.Risk factors for reported influenza and influenza-like symptoms in patients with rheumatoid arthritis.Pneumococcal vaccination in autoimmune rheumatic diseases.Vaccination against seasonal influenza is effective in Japanese patients with rheumatoid arthritis enrolled in a large observational cohort.Comparison of alternative models for linking drug exposure with adverse effects.Urinary tract infections in patients with rheumatoid arthritis.Factors Associated with Severe Skin Infections in Patients Treated with Biologic Therapies for Inflammatory Rheumatic DiseasesThe impact of exposure model misspecification on signal detection in prospective pharmacovigilance
P2860
Q28073436-65D6BEC3-FF49-4FFD-BDD8-1B8E10B4A060Q28074148-5DF1B745-A6E2-4B87-9AB9-339777E8FD72Q33623765-79BB494A-1F74-491E-AC4F-0CB5748FB52BQ34413227-6D80137B-3A33-4CB7-A08B-FAC080348906Q34905686-B66958C1-42C0-4F32-96D8-5EE00AE85CFDQ34986307-E8F946B0-2923-4C45-91CE-FE54253CAFF5Q35167257-CB2E144A-8EE4-4B99-AF9E-2C1BBD117D89Q35242249-B872258B-2048-499A-BC34-B3BCA6224FEDQ35617753-B02E11A9-1FEF-4710-B49D-7F5CF438C8D4Q35792458-8A7043EC-6FCC-481C-BE21-FBBB003ECD1CQ36033348-E43DBD01-56FB-4D53-94B7-CA4C2F366A44Q36095259-6618D36F-51D1-4293-9087-0398E322A242Q36179586-3C8CD533-DAF0-4251-ADDA-3CDE263CCEF7Q36294329-0B185AD7-D757-4C67-A287-A004C4E2B71BQ36300250-8FFE1D08-8E32-46E2-BA70-6A2AF8A2A254Q36306270-59521359-BC44-4B28-BA71-70559C8EC19CQ36574609-08270A9F-F30A-467B-8317-27E3BA73195AQ36903117-EEEC7351-E97C-4272-8CE4-4ACD828FD6B7Q37427257-AD2E14D6-F608-474E-A882-6773C00CE764Q38063474-2C69FD22-83D2-4012-9B72-0F034ED5AD35Q38182646-DAE3D698-AAAD-4D7A-8BF4-26DA2313C53CQ38254723-8A58DC82-F697-4E1A-A9A5-0DC81FAA73D6Q38642378-FBBFC5EF-5CF4-43D5-8F36-B2C9945387A3Q38701074-C37FA2A1-C543-46A7-86C3-6DFB1AAFFEB1Q38911873-140CA2B4-C0BA-41C1-B56C-82D2D6059076Q38993240-9BC7E4C8-5646-4583-B6BE-1C04FF1DA756Q40280098-AA8191A1-30E1-476C-BFFA-A44538072839Q41687129-5453A6BF-010E-4ED3-A2E7-47BEAF708F4CQ43170863-42DF90BA-4B5D-4282-9DB2-B8C3685FE605Q43843712-D86DA24C-582E-499F-AF31-F47E45469853Q51200926-A482528A-8BBA-4786-B786-785E39BD17CDQ58003948-5AC15BB6-AC0D-4552-B808-59DEE13F75A7Q58159898-2E7A8F5F-6E98-41D8-BB78-0C84A62A7D6D
P2860
Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Risk and predictors of infecti ...... ith inflammatory polyarthritis
@ast
Risk and predictors of infecti ...... ith inflammatory polyarthritis
@en
type
label
Risk and predictors of infecti ...... ith inflammatory polyarthritis
@ast
Risk and predictors of infecti ...... ith inflammatory polyarthritis
@en
prefLabel
Risk and predictors of infecti ...... ith inflammatory polyarthritis
@ast
Risk and predictors of infecti ...... ith inflammatory polyarthritis
@en
P2860
P50
P356
P1476
Risk and predictors of infecti ...... ith inflammatory polyarthritis
@en
P2093
Diane Bunn
Jarrod Franklin
P2860
P304
P356
10.1136/ARD.2006.057265
P407
P577
2006-09-19T00:00:00Z